MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-020-74568-x

Медицинская библиотека · Scientific reports · 2020

Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study.

Etzion Ohad, Dahari Harel, Yardeni David, Issachar Assaf, Nevo-Shor Anat, Cohen-Naftaly Michal, Ashur Yaffa, Uprichard Susan L, Arbib Orly Sneh, Munteanu Daniela, Braun Marius, Cotler Scott J, Abufreha Naim, Keren-Naus Ayelet, Shemer-Avni Yonat, Mor Orna, Murad Jayanah, Novack Victor, Shlomai Amir

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

The advent of direct-acting antivirals (DAAs) has transformed the landscape of hepatitis C virus (HCV) management. We aimed to prospectively (real-time) evaluate the feasibility of using a response-guided therapy approach, based on mathematical modeling of early viral kinetics, to reduce the duration of DAAs therapy. Patients were treated with DAAs according to the physicians' preference. HCV was measured at baseline and at day 2 and weeks 1, 2 and 4 after treatment initiation. The primary endpoint was the proportion of patients with sustained-virological response (SVR) at 12 and/or 24 weeks post-treatment. Twenty-nine patients (mean age 54 ± 16, 44% females, 73% with HCV genotype 1), were enrolled and all completed therapy. Treatment duration was shortened in 11 of the 29 patients (38%). SVR was achieved in 28 of the 29 patients (97%). Relapse occurred post treatment in a single case of a non-cirrhotic male with genotype 3, who was treated with sofosbuvir/velpatasvir for 6 weeks. Virus sequencing did not identify baseline or treatment emergent resistance associated substitutions. Real-time mathematical modeling of early HCV kinetics can be utilized for shortening DAAs duration in approximately 40% of patients without compromising treatment efficacy.Clinical trial registration: ClinicalTrials.gov Identifier: NCT03603327.

Для цитирования: Etzion Ohad, Dahari Harel, Yardeni David, Issachar Assaf, Nevo-Shor Anat, Cohen-Naftaly Michal, Ashur Yaffa, Uprichard Susan L, Arbib Orly Sneh, Munteanu Daniela, Braun Marius, Cotler Scott J, Abufreha Naim, Keren-Naus Ayelet, Shemer-Avni Yonat, Mor Orna, Murad Jayanah, Novack Victor, Shlomai Amir. Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study.. Scientific reports. 2020. DOI: 10.1038/s41598-020-74568-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.